ONCO NOSTIC TECHNOLOGIES INC — Department of Health and Human Services SBIR Phase II: IN Vitro Diagnostic Test for Basal-Like Breast Cancer - A molecular diagnostic test based
ONCO NOSTIC TECHNOLOGIES INC — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $995,819
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- NAICS
- —
- Place of performance
- IL
- Period
- —
Description
IN Vitro Diagnostic Test for Basal-Like Breast Cancer - A molecular diagnostic test based on detection of transcription factor FOXC1 at the protein and RNA level will be developed to accurately diagnose basal-like breast cancer (BLBC). PUBLIC HEALTH RELEVANCE